GlassScriptPhysician profile
Tom C Zhou
NPI 1194106492
$3,956.63
in general payments reported to CMS, 2019-2025
17 companies · $2,350 in 2025
The $2,350 reported for 2025 was more than what 91% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $125 · 2021: $336 · 2023: $138 · 2024: $1,008 · 2025: $2,350.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,392 · Travel and Lodging: $1,105.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,391.55 |
| Travel and Lodging | $1,104.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,638.39 | 2021-2025 | Scopis Ent, Core, Xpress Loprofile |
| Inspire Medical Systems, INC. | $1,211.08 | 2020-2025 | Inspire |
| Glaxosmithkline, LLC. | $259.46 | 2024-2025 | Nucala |
| Genzyme Corporation | $156.62 | 2024-2025 | |
| Tactile Systems Technology INC | $105.99 | 2024-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Regeneron Healthcare Solutions, INC. | $100.89 | 2023-2025 | Dupixent |
| Medtronic, INC. | $80.78 | 2024-2025 | Pteye Parathyroid Detection System, Propel |
| Abbvie INC. | $78.13 | 2025 | |
| Kls-Martin L.P. | $63.75 | 2024-2025 | |
| Amgen INC. | $50.36 | 2024-2025 | Tavneos |
| Hologic Sales and Service, LLC | $47.58 | 2024-2025 | Coolseal Generator |
| E.R. Squibb & Sons, L.L.C. | $45.00 | 2023 | Opdivo |
| Organogenesis INC. | $32.27 | 2024-2025 | Affinity, Novachor |
| Aerin Medical INC. | $26.55 | 2025 | |
| Cochlear Americas | $24.46 | 2025 | Baha, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Osia Osi300 Implant |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $21.57 | 2025 | Tula |
| Optinose US, INC. | $13.75 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tom Zhou listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.